Myomo share price logo

Myomo

AMEX: MYO

$1.48

+0.15

(+11.28%)

as on

Myomo Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.31
    $1.51
    downward going graph

    11.49%

    Downside

    2.03%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.61
    $1.89
    downward going graph

    59.12%

    Downside

    27.36%

    Upside

    downward going graph

Myomo share price movements today

Previous Close
$1.33
Open
$1.33
Volume
1.3M
Market Cap
$51.1M
Day's Low - High
$1.31 - $1.51
52 Week Low - High
$0.61 - $1.89

Myomo Historical Returns

1 Month Return
-28.49 %
3 Month Return
+ 3.91 %
1 Year Return
+ 52.87 %
3 Year Return
+ 9.02 %
5 Year Return
-88.66 %

Myomo Stock Fundamentals & Key Indicators

Check Myomo market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$51.1M

EPS (TTM)

-0.3404

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.91

Industry PE ratio

-2.33

PEG Ratio

0.09308031404852304

EBITDA

-11.4M

Revenue (TTM)

43.3M

Profit Margin

68.35%

Return On Equity TTM

-142.02%

Myomo Stock Valuation

Track how Myomo P/E has moved over time to understand its valuation trends.

Myomo in the last 5 years

  • Overview

  • Trends

Lowest (-40.25x)

December 31, 2024

Today (-2.46x)

December 31, 2025

Industry (-2.33x)

December 31, 2025

Highest (-0.34x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -2.46x

Myomo vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Myomo with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$51.1M-88.66%-3.9168.35%0.00%
BUY$50.9B-26.1%50.7277.98%0.00%
BUY$119.9B-28.47%22.6866.69%3.08%
BUY$176.6B-19.37%32.8156.80%2.42%
BUY$108.0B2.6%28.7965.17%1.22%

Stock Returns calculator for Myomo Stock including INR - Dollar returns

The Myomo stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Myomo investment value today

Current value as on today

₹1,84,915

Returns

₹84,915

(+84.92%)

Returns from Myomo Stock

₹70,115 (+70.11%)

Dollar Impact

₹14,800 (+14.8%)

Analyst Recommendation on Myomo Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Myomo. Average target price of $4.64

Myomo Share Price Target

Get share price movements and forecasts by analysts on Myomo.

What analysts predicted

68.1%UPSIDE

Target Price

$4.64

Current Price

$1.48

Analyzed by

5 Analysts

Target

$4.64

Myomo target price $4.64, a slight upside of 68.1% compared to current price of $1.48. According to 5 analysts rating.

Indian Investors' Interest in Myomo Stock

Search interest for Myomo Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:8% versus previous 30 day period

Myomo Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
3
7
9
12
9
9
10
11
10
11
Gross Profit
2
5
6
8
6
6
6
7
6
8
Operating Income
-3
-1
0
0
-3
-4
-3
-2
-3
-2
EBITDA
-3
0
0
0
-2
-4
-3
-2
-2
-3
Interest Expense
-
-
-
-
-
-
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
-
-
Income Before Tax
-3
-1
0
0
-3
-4
-3
-3
-2
-3
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-3
-1
0
0
-3
-4
-3
-3
-3
-4
Net Profit Margin
61.24%
70.81%
75.43%
71.39%
67.23%
62.70%
63.84%
68.56%
68.24%
72.13%

Myomo Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
2
3
7
13
15
19
32
40
Gross Profit
1
1
2
4
10
10
13
23
26
Operating Income
-6
-10
-10
-10
-10
-10
-8
-6
-14
EBITDA
-6
-10
-10
-10
-9
-10
-7
-5
-12
Interest Expense
0
0
0
0
-
-
-
-
0
Depreciation
0
0
0
0
0
0
0
0
1
Income Before Tax
-12
-10
-10
-11
-10
-10
-7
-5
-15
Income Tax Expense
-
-
-
-
0
0
0
0
0
Net Income
-12
-10
-10
-11
-10
-10
-8
-6
-15
Net Profit Margin
67.59%
70.20%
76.09%
65.71%
74.42%
65.91%
68.51%
71.23%
65.70%

Myomo Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-1
0
0
-3
-4
-3
-3
-3
3
Operating Cash Flow
-3
-1
-1
3
-2
-8
-1
-1
-2
-1
Investing Cash Flow
-3
2
2
-1
-1
0
0
-4
0
2
Financing Cash Flow
5
-
0
15
0
4
0
7
-
0
Change in Cash
-1
0
1
17
-4
-5
-1
1
-2
0

Myomo Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-10
-10
-11
-10
-10
-8
-6
-15
Operating Cash Flow
-6
-9
-10
-9
-9
-10
-6
-3
-14
Investing Cash Flow
0
0
0
0
0
0
-2
0
-7
Financing Cash Flow
18
3
8
16
13
0
9
20
11
Change in Cash
12
-6
-2
7
3
-10
1
17
-10

Mutual Funds that own Myomo Stock

Check out the Mutual Funds with significant holdings in Myomo.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.889134%
1144324
Fidelity Salem Street Trust
0.967795%
383323
Fidelity Concord Street Trust
0.665683%
263663
VANGUARD SCOTTSDALE FUNDS
0.515248%
204079
SCHWAB CAPITAL TRUST
0.205933%
81566

Global Institutional Holdings in Myomo

Funds
Holdings
Vanguard
4.08%
Bridgeway
0.1%

Myomo News & Key Events

  • img

    Today's Timeline - 09 March

    Tue, 01:35 AM

    -

    Myomo enters network participation agreements with Elevance Health, expanding access to MyoPro® for over 80 million covered lives.

Insights on Myomo

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MYO stock has moved up by 13.8%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 10.11M → 11.70M (in $), with an average increase of 13.6% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MYO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, MYO has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -3.00M → -4.02M (in $), with an average decrease of 33.6% per quarter

About Myomo

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
OrganisationMyomo
Headquarters45 Blue Sky Dr., Burlington, MA, 01803, US
IndustryMedical - Devices
CEOPaul R. Gudonis
E-voting on sharesClick here to vote

Key Management of Myomo

Name

Title

Mr. Micah J. Mitchell

Chief Commercial Officer

Ms. Kathy Sawyers

Sr. Director of Clinical Outcomes

Mr. Malcolm G. Bock

Vice President of Engineering & Product Strategy

Mr. Paul R. Gudonis

President, CEO & Chairman

Mr. David A. Henry

Chief Financial Officer

Dr. Harry Kovelman M.D.

Chief Medical Officer

Mr. Colin Anderson

Global Director of Operations

Ms. Galina Shtivelman

Senior Director of Human Resources

FAQs

What is Myomo share price today?

Myomo share price today is $1.48 as on at the close of the market. Myomo share today touched a day high of $1.51 and a low of $1.31.

What is the 52 week high and 52 week low for Myomo share?

Myomo share touched a 52 week high of $1.89 on and a 52 week low of $0.61 on . Myomo stock price today i.e. is closed at $1.48,which is 21.49% down from its 52 week high and 144.63% up from its 52 week low.

What is Myomo's market capitalisation today?

Myomo market capitalisation is $0.00T as on .

How to invest in Myomo Stock (MYO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Myomo on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Myomo Shares that will get you 1.0135 shares as per Myomo share price of $1.48 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Myomo Stock (MYO) from India?

Indian investors can start investing in Myomo (MYO) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Myomo stock (as per the Rupee-Dollar exchange rate as on ). Based on Myomo share’s latest price of $1.48 as on September 19, 2026 at 8:45 am IST, you will get 6.7568 shares of Myomo. Learn more about fractional shares .

What are the returns that Myomo has given to Indian investors in the last 5 years?

Myomo stock has given -88.66% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?